MicroRNA-200 (miR-200); Fas receptor (CD95); protein tyrosine phosphatase non-receptor type 13 (PTPN13; FAP-1) BriefCommunication Pages: 789 - 789
Purinergic receptor P2X ligand-gated ion channel 4 (P2X4; P2RX4); prostaglandin E2 (PGE2) BriefCommunication Pages: 795 - 795
Improving aptamer screening using nucleic acid libraries containing high degrees of secondary structures BriefCommunication Pages: 800 - 800
In vivo screening to identify genes mutated in Mycobacterium tuberculosis that alter bacterial sensitivity to antibiotics specifically in the in vivo environment BriefCommunication Pages: 801 - 801
A library of 472 secreted and transmembrane protein knockout mice BriefCommunication Pages: 804 - 804
Cytochrome c–encapsulating nanoparticles for cancer therapy and imaging BriefCommunication Pages: 805 - 805
Dendrimer-mAb–based drug delivery specific to tumors expressing HER2 (ERBB2; neu) BriefCommunication Pages: 806 - 806
Peptide drug delivery via cleavable albumin-binding peptide conjugates BriefCommunication Pages: 807 - 807
Transplantable recellularized liver graft using decellularized liver matrix BriefCommunication Pages: 809 - 809
β-Lactamase (LACTB) reporter enzyme fluorescence (REF) to detect tuberculosis (TB) infection BriefCommunication Pages: 810 - 810
Breast cancer early onset (BRCA) profile for predicting chemotherapy responsiveness and patient outcome in epithelial ovarian cancer BriefCommunication Pages: 811 - 811
RE1-silencing transcription factor (REST; NRSF)-based breast cancer prognosis BriefCommunication Pages: 813 - 813